SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLDX Celldex Therapeudics
CLDX 24.75-7.4%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (6)12/27/2018 11:11:23 AM
From: scaram(o)uche  Read Replies (1) of 105
 
I'll continue with other projects when I have time/inclination (today is dedicated to building hurdles, the virtual kind). If anyone wants to add stuff.... financials, etc.? That would be cool.

Ten years ago, if I'd had a miserable life-challenge with cancer? I'd have desperately tried to get into this trial (CDX-301 combo), had it existed...... clinicaltrials.gov

Believe most who have worked in field of antigen presentation would have done the same. It's just so damn logical/sexy..... drive proliferation and then activate the suckers, get those weakly immunogenic cancers!!

However, I'd have watched ten years of failure in related projects.

Again, open label trial, and the share is trading at a good discount to cash/share, shareholder equity/share, etc. Buyer beware.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext